Hyaluronic Acid at its best
Profhilo is a new breakthrough skin treatment developed by IBSA, a multinational pharmaceutical corporation, owner of 65 exclusive registered patents worldwide.
Profhilo introduces a new category in the injectables market – bio remodeling. It is not a dermal filler, nor is it a skin revitalizer. Profhilo is an injectable, stabilized Hyaluronic Acid based product, designed to remodel multi-layer skin tissue.
It is an anti-aging product that treats the source of aging and not only the aging symptoms:
-
Stimulates the fibroblast cells, thereby increasing collagen and elastin production.
-
Activates the keratinocytes to increase the synthesis of collagen and elastin.
-
Preserves and encourages the viability of adipocytes that affect the quality of adipose tissue.
The Natural Solution
- Profhilo is composed of a highly-pure Hyaluronic Acid produced according to a patented technology (NAHYCO). Its unique composition features the highest concentrations of hyaluronic acid available in the market.
- Profhilo contains 64 mg of pure hyaluronic acid (HA), produced without the use of chemical cross-linking agents (BDDE).
- Its innovative nature goes beyond its components and production and onto the unique delivery method, requiring fewer injections and sessions, treating even the most challenging areas such as the neck and upper hands.
Less Is More
Profhilo is a new breakthrough skin treatment developed by IBSA, a multinational pharmaceutical corporation, owner of 65 exclusive registered patents worldwide.
-
Reduced number of treatments sessions
-
Reduced number of injections sites = Reduced discomfort
-
Reduced or eliminated downtime
Available in 56 Countries
by end of 2018
Over 1,500,000 Treatments Preformed July 2020
Over 1,500,000 Treatments Preformed July 2020